HealthQuest Capital
VC Fund
Menlo Park, United States
HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry
- Total investments:
- 57
- Last investment:
- Lead investor:
- 58%
Last updated:
For AI agents: llms.txt
Industries HealthQuest Capital invests in
Stages HealthQuest Capital invests in
Countries HealthQuest Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Garheng Kong
|
|||
Conrad Wang
|
|||
David Kabakoff
|
|||
Emmett Cunningham
|
|||
Garheng Kong
|
|||
| See all 9 contacts → | |||
Investment Focus
Industry
- Health Care 34 (60%)
- Medical Device 15 (26%)
- Health Diagnostics 11 (19%)
- Medical 9 (16%)
- Biotechnology 8 (14%)
Stage
- Series B 10 (18%)
- Series C 10 (18%)
- Funding Round 10 (18%)
- Venture - Series Unknown 6 (11%)
- Series D 3 (5%)
Country
- United States 34 (60%)
- United Kingdom 2 (4%)
- Canada 1 (2%)
- South Korea 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Garheng Kong
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 7 | Find email | |
|
Conrad Wang
Partner
|
Partner | Total investments: 2 | Find email | |
|
David Kabakoff
Partner
|
Partner | Total investments: 9 | Find email | |
|
Emmett Cunningham
Senior Partner
|
Senior Partner | Total investments: 2 | Find email | |
|
Garheng Kong
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 10 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Connie Health
|
Connie Health empowers older Americans to make confident, worry-free healthcare decisions. | $40M / Series B / Jun 18, 2026 | |
AnswersNow
|
AnswersNow is an app that revolutionized autism support by utilizing the use of technology. All of their clinicians are board-certified behavioral analysts. With thousands of hours of training, ongoing certifications, and master's level education requirements. | $40M / Series B / Jan 21, 2026 | |
Diana Health
|
Diana Health offers personalized women's healthcare services in maternity, gynecology, menopause, mental health, and wellness. It supports women at various life stages, from new to women’s health, through pregnancy and menopause, by addressing both everyday health needs and more complex concerns like abnormal bleeding, PCOS, pelvic pain, andsexual or urinary issues. Care is tailored through collaborative care teams that include OB/GYNs, Certified Nurse Midwives, and Nurse Practitioners, depending on the patient’s preferences and medical needs. Diana Health integrates physical, social, and emotional health into each care plan, using digital tools, longer appointments, and educational resources to make the care experience more personal. | $55M / Series C / Sep 11, 2025 | |
HistoSonics
|
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels. | Private Equity / Aug 07, 2025 | |
Alpheus Medical
|
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers. Alpheus Medical also provides a non-invasive drug-device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM). | $52M / Series B / May 15, 2025 | |
hellocare
|
Solaborate is a communication platform company. We believe that reinventing and simplifying communication tools and services represents our greatest opportunity to improve people’s lives and help our planet. Our products empower people to stay connected, improve productivity, and provide better work-life balance.We have a diverse team at officesspread out in the US, China, and Kosovo. As part of our commitment to inclusion and diversity, we cultivate an empathetic workspace, a listening environment, always learning and getting inspired by our community. We grow together and dream about the next thing to create together. | $47M / Venture - Series Unknown / Apr 15, 2025 | |
OrganOx
|
OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford. | $160M / Venture - Series Unknown / Feb 24, 2025 | |
Royal Solutions Group
|
Royal Solutions Group is an IT company that provides software and services to its clients nationwide in the healthcare industry. The company offers a collective experience in technology, financial services, management consulting, and healthcare fields. Their product offerings focus on patient and provider workflows, delivered through a suite ofintegrated products.Royal Solutions Group's suite of solutions, focuses on the patient, provider, and operational workflows, optimizing engagement in all areas of a patient exam life cycle. The Solutions include RoyalPay for insurance verification, estimation, prior authorization, and streamlined payment processing, Royal Kiosks for patient pre-registration, paperless on-site registration, access, and engagement and RoyalMD for complete practice and referral management and Royal Alerts for robust messaging and notifications and the Report Guard for encryption, connectivity, and interoperability services.Royal Solutions Group was founded in 2008 and is headquartered in Yorktown Heights, NY, USA. | Venture - Series Unknown / Dec 23, 2024 | |
Cellipont Bioservices
|
Cellipont Bioservices is a cell therapy CDMO that specializes in cell therapy development and small-to-large batch production. | Oct 07, 2024 | |
|
HistoSonics
|
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels. | $102M / Series D / Aug 15, 2024 | |
| See all 57 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does HealthQuest Capital invest in?
HealthQuest Capital invests primarily in Health Care, Medical Device and Health Diagnostics startups, most often at Series B and Series C stage. Most of the 57 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact HealthQuest Capital?
Public channels for HealthQuest Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HealthQuest Capital?
The team at HealthQuest Capital includes Garheng Kong (Founder and Managing Partner), Conrad Wang (Partner) and David Kabakoff (Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
